{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:27:18Z","timestamp":1783081638810,"version":"3.54.6"},"reference-count":55,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.vaccine.2018.02.071","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T09:06:33Z","timestamp":1519376793000},"page":"1720-1727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["New and safe formulation for scorpion immunotherapy: Comparative study between saponin and FCA adjuvants associated to attenuated venom"],"prefix":"10.1016","volume":"36","author":[{"given":"Abdelmounaim","family":"Nouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faez Amokrane","family":"Nait Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Laraba-Djebari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.071_b0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1590\/S1678-91992012000400008","article-title":"Incidence and severity of scorpion stings in Algeria","volume":"18","author":"La\u00efd","year":"2012","journal-title":"J Venomous Anim Toxins Incl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.02.071_b0010","doi-asserted-by":"crossref","first-page":"903295","DOI":"10.1155\/2010\/903295","article-title":"Scorpion venom and the inflammatory response","volume":"2010","author":"Petricevich","year":"2010","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.vaccine.2018.02.071_b0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.etp.2008.03.006","article-title":"Pathophysiological effects of Androctonus australis hector scorpion venom: tissue damages and inflammatory response","volume":"60","author":"Adi-Bessalem","year":"2008","journal-title":"Exp Toxicol Pathol: Off J Gesellschaft F\u00fcr Toxikol Pathol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0020","doi-asserted-by":"crossref","unstructured":"Laraba-Djebari F, Adi-Bessalem S, Hammoudi-Triki D. Scorpion venoms: pathogenesis and biotherapies. scorpion venoms. Dordrecht: Springer, Netherlands; 2015. p. 63\u201385. http:\/\/doi.org\/10.1007\/978-94-007-6404-0_2.","DOI":"10.1007\/978-94-007-6404-0_2"},{"key":"10.1016\/j.vaccine.2018.02.071_b0025","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0041-0101(94)90382-4","article-title":"Approaches to the treatment of scorpion envenoming","volume":"32","author":"Freire-Maia","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2018.02.071_b0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1590\/S1678-91992006000300004","article-title":"Optimization of antiscorpion venom production","volume":"12","author":"Ozkan","year":"2006","journal-title":"J Venomous Anim Toxins Incl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.02.071_b0035","first-page":"400","article-title":"A retrospective review of lesions associated with the use of Freund\u2019s adjuvant","volume":"39","author":"Broderson","year":"1989","journal-title":"Lab Anim Sci"},{"key":"10.1016\/j.vaccine.2018.02.071_b0040","first-page":"364","article-title":"Posterior paresis induced by Freund\u2019s adjuvant in guinea pigs","volume":"43","author":"Kleinman","year":"1993","journal-title":"Lab Anim Sci"},{"key":"10.1016\/j.vaccine.2018.02.071_b0045","first-page":"424","article-title":"The local and systemic effects of Freund\u2019s adjuvant and its fractions","volume":"70","author":"Steiner","year":"1960","journal-title":"Arch Pathol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0050","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.vaccine.2005.01.116","article-title":"The use of oil adjuvants in therapeutic vaccines","volume":"24","author":"Aucouturier","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.071_b0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ilar.37.3.141","article-title":"Institutional policies and guidelines on adjuvants and antibody production","volume":"37","author":"Jackson","year":"1995","journal-title":"ILAR J"},{"key":"10.1016\/j.vaccine.2018.02.071_b0060","unstructured":"Grumstrup-Scott. Guidelines for the use of adjuvants in research special emphasis on Freund\u2019s adjuvant; 1989. <http:\/\/oacu.od.nih.gov\/ARAC\/documents\/Adjuvants.pdf> [accessed April 9, 2016]."},{"key":"10.1016\/j.vaccine.2018.02.071_b0065","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","article-title":"Advances in saponin-based adjuvants","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.071_b0070","doi-asserted-by":"crossref","unstructured":"Marty-Roix R, Vladimer GI, Pouliot K, Weng D, Buglione-Corbett R, West K, et al. Identification of QS-21 as an inflammasome-activating molecular component of saponin adjuvants; 2015. http:\/\/doi.org\/10.1074\/jbc.M115.683011.","DOI":"10.1074\/jbc.M115.683011"},{"key":"10.1016\/j.vaccine.2018.02.071_b0075","doi-asserted-by":"crossref","unstructured":"Ma J, Bulger PA, Davis D vR, Perilli-Palmer B, Bedore DA, Kensil CR, et al. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi. Vaccine 1994;12:925\u201332. http:\/\/doi.org\/10.1016\/0264-410X(94)90036-1.","DOI":"10.1016\/0264-410X(94)90036-1"},{"key":"10.1016\/j.vaccine.2018.02.071_b0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1365-3083.1999.00603.x","article-title":"Quillaja saponin formulations that stimulate proinflammatory cytokines elicit a potent acquired cell-mediated immunity","volume":"50","author":"Behboudi","year":"1999","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/978-1-4615-1823-5_22","article-title":"Structural and immunological characterization of the vaccine adjuvant QS-21","volume":"6","author":"Kensil","year":"1995","journal-title":"Pharm Biotechnol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.vaccine.2005.07.097","article-title":"Crude saponins improve the immune response to an oral plant-made measles vaccine","volume":"24","author":"Pickering","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.071_b0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1631\/jzus.2007.B0153","article-title":"Adjuvant effects of saponins on animal immune responses","volume":"8","author":"Rajput","year":"2007","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.vaccine.2018.02.071_b0100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nchem.1963","article-title":"Development of a minimal saponin vaccine adjuvant based on QS-21","volume":"6","author":"Fern\u00e1ndez-Tejada","year":"2014","journal-title":"Nat Chem"},{"key":"10.1016\/j.vaccine.2018.02.071_b0105","first-page":"4260","volume":"28","author":"Ragupathi","year":"2011","journal-title":"NIH Public Access"},{"key":"10.1016\/j.vaccine.2018.02.071_b0110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00436-016-5303-z","article-title":"Immunization of rhesus macaques with Echinococcus multilocularis recombinant 14\u20133-3 antigen leads to specific antibody response","volume":"116","author":"Lampe","year":"2017","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2018.02.071_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13567-014-0135-2","article-title":"Functional analysis of bovine TLR5 and association with IgA responses of cattle following systemic immunisation with H7 flagella","volume":"46","author":"Tahoun","year":"2015","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2018.02.071_b0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1586\/erv.11.18","article-title":"Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer","volume":"10","author":"Ragupathi","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.02.071_b0125","first-page":"1049","article-title":"P. Saponins as immunoadjuvant agent: a review","volume":"8","author":"de Barbosa","year":"2014","journal-title":"Afr J Pharm Pharmacol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0130","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1139\/y03-115","article-title":"Effect of gamma irradiation on toxicity and immunogenicity of Androctonus australis hector venom","volume":"81","author":"Abib","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0135","unstructured":"National Institutes of Health. Public health service policy on humane care and use of laboratory animals; 2015. p. 1\u201328."},{"key":"10.1016\/j.vaccine.2018.02.071_b0140","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.intimp.2008.05.011","article-title":"Combination of two antibody fragments F(ab\u2032)(2)\/Fab: an alternative for scorpion envenoming treatment","volume":"8","author":"Sami-Merah","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0145","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.vaccine.2008.11.103","article-title":"Comparison of montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) alongwith incomplete Freund\u2019s adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom","volume":"27","author":"Waghmare","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.071_b0150","doi-asserted-by":"crossref","unstructured":"Christensen PA. Production and standardization of antivenin. Berlin, Heidelberg: Springer; 1979. p. 825\u201346. http:\/\/doi.org\/10.1007\/978-3-642-66913-2_20.","DOI":"10.1007\/978-3-642-66913-2_20"},{"key":"10.1016\/j.vaccine.2018.02.071_b0155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ilar.46.3.280","article-title":"Adjuvants and antibody production: dispelling the myths associated with Freund\u2019s complete and other adjuvants","volume":"46","author":"Stils","year":"2005","journal-title":"ILAR J"},{"key":"10.1016\/j.vaccine.2018.02.071_b0160","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2249.2002.01774.x","article-title":"Antigen presentation by macrophages is enhanced by the uptake of necrotic, but not apoptotic, cells","volume":"127","author":"Barker","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0165","doi-asserted-by":"crossref","unstructured":"Barnes PF, Chatterjee D, Abrams JS, Lu S, Wang E, Yamamura M, et al. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (Baltimore, Md: 1950) 1992;149:541\u20137.","DOI":"10.4049\/jimmunol.149.2.541"},{"key":"10.1016\/j.vaccine.2018.02.071_b0170","doi-asserted-by":"crossref","unstructured":"Roach TI, Barton CH, Chatterjee D, Blackwell JM. Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. J Immunol (Baltimore, Md: 1950) 1993;150:1886\u201396.","DOI":"10.4049\/jimmunol.150.5.1886"},{"key":"10.1016\/j.vaccine.2018.02.071_b0175","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.02.071_b0180","doi-asserted-by":"crossref","unstructured":"Ohashi K, Burkart V, Floh\u00e9 S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol (Baltimore, Md: 1950) 2000;164:558\u201361.","DOI":"10.4049\/jimmunol.164.2.558"},{"key":"10.1016\/j.vaccine.2018.02.071_b0185","first-page":"488","article-title":"The response of the histiocytes and macrophages in the lungs of rabbits injected with freund\u2019s adjuvant","volume":"45","author":"Moore","year":"1964","journal-title":"Brit J Exp Pathol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0190","doi-asserted-by":"crossref","unstructured":"Green I, Benacerraf B, Stone SH. The effect of the amount of mycobacterial adjuvants on the immune response of strain 2, strain 13 and Hartley strain guinea pigs to DNP-PLL and DNP-GL. J Immunol (Baltimore, Md: 1950) 1969;103:403\u201312.","DOI":"10.4049\/jimmunol.103.3.403"},{"key":"10.1016\/j.vaccine.2018.02.071_b0195","doi-asserted-by":"crossref","first-page":"13324","DOI":"10.1038\/ncomms13324","article-title":"Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation","volume":"7","author":"den Brok","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2018.02.071_b0200","doi-asserted-by":"crossref","first-page":"46835","DOI":"10.1074\/jbc.M409340200","article-title":"Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes","volume":"279","author":"Brasaemle","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2018.02.071_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2009.11.005","article-title":"Lipid droplets finally get a little R-E-S-P-E-C-T","author":"Farese","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2018.02.071_b0210","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00011-006-5205-0","article-title":"Lipid bodies: Structural markers of inflammatory macrophages in innate immunity","volume":"55","author":"Melo","year":"2006","journal-title":"Inflamm Res"},{"key":"10.1016\/j.vaccine.2018.02.071_b0215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1371\/journal.ppat.1002729","article-title":"Lipid body-phagosome interaction in macrophages during infectious diseases: host defense or pathogen survival strategy?","volume":"8","author":"Melo","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.02.071_b0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1096\/fj.06-6711com","article-title":"Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies","volume":"21","author":"Wan","year":"2007","journal-title":"FASEB J: Off Publ Fed Am Soc Exp Biol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0225","unstructured":"Lindblad EB. Freund \u2019 s adjuvants n.d.;42."},{"key":"10.1016\/j.vaccine.2018.02.071_b0230","doi-asserted-by":"crossref","unstructured":"Fontes JA, Barin JG, Talor MV, Stickel N, Schaub J, Rose NR, et al. Complete Freund\u2019s adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune response. Immun Inflam Dis 2017:1\u201314. http:\/\/doi.org\/10.1002\/iid3.155.","DOI":"10.1002\/iid3.155"},{"key":"10.1016\/j.vaccine.2018.02.071_b0235","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1189\/jlb.70.6.849","article-title":"Modes of action of Freund\u2019s adjuvants in experimental models of autoimmune diseases","volume":"70","author":"Billiau","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0240","doi-asserted-by":"crossref","first-page":"e40745","DOI":"10.1371\/journal.pone.0040745","article-title":"Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund\u2019s adjuvant, and monophosphoryl lipid A","volume":"7","author":"Vitoriano-Souza","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2018.02.071_b0245","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.vaccine.2006.12.037","article-title":"Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges","volume":"25","author":"Fogg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.071_b0250","first-page":"435","article-title":"The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund\u2019s incomplete and complete adjuva","volume":"39","author":"Bomford","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0255","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/1044-579X(95)90007-1","article-title":"Selection of potent immunological adjuvants for vaccine construction","volume":"6","author":"McElrath","year":"1995","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0260","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0378-1135(02)00128-1","article-title":"Adjuvant regulation of cytokine profile and antibody isotype of immune responses to Mycoplasma agalactiae in mice","volume":"88","author":"Avramidis","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0265","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1096\/fasebj.6.14.1385241","article-title":"A two-signal model for regulation of immunoglobulin isotype switching","volume":"6","author":"Purkerson","year":"1992","journal-title":"FASEB J: Off Publ Fed Am Soc Exp Biol"},{"key":"10.1016\/j.vaccine.2018.02.071_b0270","doi-asserted-by":"crossref","unstructured":"Thomas Forsthuber, Hualin C. Yip PVL, Robbins DS. Induction of TH1 and TH2 immunity in neonatal mice. Science 271(5256):1728\u201330.","DOI":"10.1126\/science.271.5256.1728"},{"key":"10.1016\/j.vaccine.2018.02.071_b0275","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.vaccine.2016.04.035","article-title":"Development and characterization of a new carrier for vaccine delivery based on calcium-alginate nanoparticles: safe immunoprotective approach against scorpion envenoming","volume":"34","author":"Nait Mohamed","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:47Z","timestamp":1759400747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18302585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":55,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0264410X18302585"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New and safe formulation for scorpion immunotherapy: Comparative study between saponin and FCA adjuvants associated to attenuated venom","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}